FMP

FMP

Enter

GNPX - Genprex, Inc.

Profile of Genprex, Inc.(GNPX), Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients w

photo-url-https://financialmodelingprep.com/image-stock/GNPX.png

Genprex, Inc.

GNPX

NASDAQ

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

1.9 USD

-0.1 (-5.26%)

About

ceo

Mr. Ryan M. Confer M.S.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.

CIK

0001595248

ISIN

US3724462037

CUSIP

372446104

Address

3300 Bee Cave Road

Phone

877 774 4679

Country

US

Employee

26

IPO Date

Mar 29, 2018

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep